• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[宫颈癌患者腹主动脉旁淋巴结转移的评估]

[Evaluation of para-aortic lymph node metastases in patients with cervical cancer].

作者信息

Tsukamoto N, Saito T, Matsukuma K, Matsuyama T, Kamura T, Kaku T, Suenaga T

机构信息

Dept. of Gyne. & Obstet., Kyushu Univ. Faculty of Med.

出版信息

Gan No Rinsho. 1988 Jan;34(1):57-62.

PMID:3339849
Abstract

From 1979 to 1986, 355 patients with cervical cancer underwent paraaortic lymph node (PAN) biopsy before the start of initial treatment. Nineteen of these 355 patients (5.4%) had a positive PAN, and the percentage incidence of positive PAN in each clinical stage was as follow: stage Ib, 2.4%; IIa, 0%; IIb, 3.7%; IIIb, 19.0%; and IV, 20%. Eighteen of these 19 patients also had positive pelvic lymph nodes. Positive PANs were found to be more frequent in cases of an adenocarcinoma than in cases of squamous cancer. The palpation of the PANs seemed to be too insufficient to predict the metastasis. Patients with positive PAN who had received paraaortic irradiation survived longer than those who did not receive such treatment. It is concluded that the evaluation of the PAN is important for the management of a cervical cancer.

摘要

1979年至1986年期间,355例宫颈癌患者在初始治疗开始前接受了腹主动脉旁淋巴结(PAN)活检。这355例患者中有19例(5.4%)腹主动脉旁淋巴结阳性,各临床分期腹主动脉旁淋巴结阳性的发生率如下:Ib期,2.4%;IIa期,0%;IIb期,3.7%;IIIb期,19.0%;IV期,20%。这19例患者中有18例盆腔淋巴结也呈阳性。发现腺癌患者的腹主动脉旁淋巴结阳性比鳞状细胞癌患者更常见。对腹主动脉旁淋巴结的触诊似乎不足以预测转移情况。接受腹主动脉旁放疗的腹主动脉旁淋巴结阳性患者比未接受此类治疗的患者存活时间更长。得出的结论是,腹主动脉旁淋巴结评估对宫颈癌的治疗管理很重要。

相似文献

1
[Evaluation of para-aortic lymph node metastases in patients with cervical cancer].[宫颈癌患者腹主动脉旁淋巴结转移的评估]
Gan No Rinsho. 1988 Jan;34(1):57-62.
2
[Evaluation of paraaortic lymph node metastasis in patients with primary epithelial carcinoma of the ovary].[卵巢原发性上皮癌患者腹主动脉旁淋巴结转移的评估]
Gan No Rinsho. 1988 Jul;34(8):985-9.
3
Is systematic scalene node biopsy in pretreatment evaluation of locally advanced cervical carcinoma necessary? Systematic dissection and histopathology of left scalene node biopsies in patients with locally advanced cervical carcinoma.在局部晚期宫颈癌的预处理评估中,系统性斜角肌淋巴结活检是否必要?局部晚期宫颈癌患者左侧斜角肌淋巴结活检的系统性解剖与组织病理学研究。
Gynecol Oncol. 2006 Dec;103(3):1091-4. doi: 10.1016/j.ygyno.2006.06.029. Epub 2006 Aug 4.
4
Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.日本子宫颈癌患者孤立性主动脉旁淋巴结复发的频率及特征:一项多机构研究
Gynecol Oncol. 2006 Nov;103(2):435-8. doi: 10.1016/j.ygyno.2006.03.034. Epub 2006 May 4.
5
[A clinical and pathological study on paraaortic lymph node metastasis in uterine cervical carcinoma].子宫颈癌腹主动脉旁淋巴结转移的临床与病理研究
Nihon Sanka Fujinka Gakkai Zasshi. 1994 Dec;46(12):1343-50.
6
[An evaluation of para-aortic and pelvic lymph node metastases in patients with endometrial carcinoma].[子宫内膜癌患者腹主动脉旁及盆腔淋巴结转移情况评估]
Gan No Rinsho. 1987 Oct;33(13):1705-11.
7
Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.早期宫颈癌:基于彻底的子宫旁组织切除术和巨检研究对淋巴结受累自然病程的重新定义。
Cancer. 2000 May 15;88(10):2267-74.
8
[The incidence and clinical significance of paraaortic lymph node metastases in patients with uterine cervical cancer].[子宫颈癌患者腹主动脉旁淋巴结转移的发生率及临床意义]
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Jan;42(1):60-6.
9
Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study.子宫颈癌腹主动脉旁淋巴结预防性照射。一项前瞻性随机研究。
Strahlenther Onkol. 1995 Nov;171(11):655-60.
10
Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.淋巴结阳性宫颈癌的扩散模式:局部控制与远处转移之间的关系。
Cancer J Sci Am. 1996 Sep-Oct;2(5):256-62.